Sylvester Comprehensive Cancer Center, University of Miami | Strategic Alliance Partners

February 15, 2016

Epigenetic therapy has emerged as a novel approach, not necessarily by killing cancer cells, but perhaps by altering the network of chemical changes that affect the DNA/chromatin within cancer cells.

December 02, 2015

Jonathan C. Trent, MD, associate director for Clinical Research, director of the Sarcoma Medical Research Program at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, discusses sequencing trabectedin (Yondelis) for patients with soft tissue sarcoma.

November 24, 2015

Mohammad Jahanzeb, MD, discusses emerging strategies in the adjuvant treatment of patients with HER2-positive breast cancer.

October 16, 2015

Determining the best course of treatment for sarcomas of the bone and soft tissues is a complex process.

October 09, 2015

Mohammad Jahanzeb, MD, discusses therapeutic agents that may fit into the adjuvant setting treatment paradigm for HER2-positive breast cancer, the increasing importance of genomic testing, and individualized treatments as multiple agents emerge.

August 04, 2015

Mohammad Jahanzeb, MD, professor of Clinical Medicine, Hematology Oncology, University of Miami's Miller School of Medicine, discusses potential mechanisms for overcoming HER2 resistance in breast cancer.

July 23, 2015

OncLive  editorial, marketing teams will share news about Sylvester Center.

July 22, 2015

Mohammad Jahanzeb, MD, discusses impactful studies and other key issues in HER2-positive breast cancer.

June 24, 2015

Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine will be one of the sites offering the landmark precision medicine trial, NCI-MATCH – a trial that will open to patient enrollment in July.

June 24, 2015

Erin N. Kobetz, PhD, MPH, has been named Senior Associate Dean for Health Disparity at the University of Miami Miller School of Medicine.

June 24, 2015

Invention opens pathway for more personalized treatments.

June 24, 2015

Ricardo J. Komotar, M.D., Director of Surgical Neuro-oncology at UHealth – University of Miami Health System, is the first neurosurgeon in Miami-Dade and Broward counties to remove a brain tumor using the NICO BrainPath system.

May 01, 2015

Stephen D. Nimer, MD, Director, Professor of Medicine, Sylvester Comprehensive Cancer Center discusses the challenges of treating myelodysplastic syndromes (MDS).

May 16, 2011

The oncology community is paying fresh attention to the often painful skeletal-related events in patients with bone metastases.

March 02, 2011

The Sylvester Comprehensive Cancer Center (SCCC), part of the University of Miami Health System, first opened its doors in 1992. Over the years, the SCCC has become the hub of cancer research in the region.